Zydus receives EIR for the injectable facility located at Jarod

This inspection was conducted following the warning letter issued by the USFDA

Zydus has received the Establishment Inspection Report (EIR) from the USFDA for a GMP follow-up inspection conducted at its injectable facility located at Jarod, Vadodara from August 25 to September 5, 2025 and classifying the facility as Voluntary Action Indicated (VAI).

This inspection was conducted following the warning letter issued on August 29, 2024 by the USFDA.